Sahin U - Search Results

1

Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U. Kreiter S, et al. Among authors: sahin u. Nature. 2015 Apr 30;520(7549):692-6. doi: 10.1038/nature14426. Epub 2015 Apr 22. Nature. 2015. PMID: 25901682 Free PMC article.

2

Serological analysis of human tumor antigens: molecular definition and implications.

Türeci O, Sahin U, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Mol Med Today. 1997 Aug;3(8):342-9. doi: 10.1016/s1357-4310(97)01081-2. Mol Med Today. 1997. PMID: 9269687 Review.

3

Serological identification of human tumor antigens.

Sahin U, Türeci O, Pfreundschuh M. Sahin U, et al. Curr Opin Immunol. 1997 Oct;9(5):709-16. doi: 10.1016/s0952-7915(97)80053-2. Curr Opin Immunol. 1997. PMID: 9368781 Review.

4

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.

Türeci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5211-6. doi: 10.1073/pnas.95.9.5211. Proc Natl Acad Sci U S A. 1998. PMID: 9560255 Free PMC article.

5

Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.

Türeci O, Sahin U, Zwick C, Neumann F, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Hybridoma. 1999 Feb;18(1):23-8. doi: 10.1089/hyb.1999.18.23. Hybridoma. 1999. PMID: 10211784

6

A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.

Türeci O, Sahin U, Koslowski M, Buss B, Bell C, Ballweber P, Zwick C, Eberle T, Zuber M, Villena-Heinsen C, Seitz G, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Oncogene. 2002 May 30;21(24):3879-88. doi: 10.1038/sj.onc.1205481. Oncogene. 2002. PMID: 12032826

7

Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.

Koslowski M, Türeci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U. Koslowski M, et al. Among authors: sahin u. Cancer Res. 2002 Nov 15;62(22):6750-5. Cancer Res. 2002. PMID: 12438276

8

Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles.

Türeci O, Ding J, Hilton H, Bian H, Ohkawa H, Braxenthaler M, Seitz G, Raddrizzani L, Friess H, Buchler M, Sahin U, Hammer J. Türeci O, et al. Among authors: sahin u. FASEB J. 2003 Mar;17(3):376-85. doi: 10.1096/fj.02-0478com. FASEB J. 2003. PMID: 12631577

9

Autoimmunity seen through the SEREX-scope.

Krebs P, Kurrer M, Sahin U, Türeci O, Ludewig B. Krebs P, et al. Among authors: sahin u. Autoimmun Rev. 2003 Oct;2(6):339-45. doi: 10.1016/s1568-9972(03)00047-8. Autoimmun Rev. 2003. PMID: 14550875 Review.

10

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

Krause P, Türeci O, Micke P, Buhl R, Huber C, Sahin U. Krause P, et al. Among authors: sahin u. J Immunol Methods. 2003 Dec;283(1-2):261-7. doi: 10.1016/j.jim.2003.09.014. J Immunol Methods. 2003. PMID: 14659917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters